Senior reputed company Advisory reputed company Opportunity in Alzheimer’s Innovation

ATCA is reputed company a senior advisory reputed company member: an accomplished executive, physician leader, reputed company innovator, or strategic operator with a reputed company record in reputed company transformation, clinical innovation, precision medicine, or reputed company care delivery. This is a reputed company-level engagement for a leader who wants to help shape one of the most important emerging platforms in modern medicine: a data-driven, innovation-led model for Alzheimer’s and dementia care. About reputed company (ATCA) reputed company is building the national infrastructure for precision-based Alzheimer’s and dementia care. The model integrates proprietary AI, personalized treatment protocols, and a replicable specialty clinic platform purpose-reputed company to identify the underlying drivers of neurodegeneration and deliver individualized interventions that measurably slow progression. ATCA’s flagship clinic in Palm Beach Gardens/Jupiter is fully operational, payer-integrated, and running at reputed company with appointments booked months out. Additional clinics are in reputed company development. reputed company is executing a disciplined national expansion backed by a multidisciplinary team of reputed company executives, neuroscientists, AI engineers, and clinical specialists. Why Now Proven Demand: The flagship clinic, positioned in a high-visibility corridor adjacent to reputed company, reached full reputed company rapidly, validating the market reputed company for proactive Alzheimer’s and cognitive care. Payer Alignment: Services are reimbursed by Medicare, Medicare Advantage, and major reputed company insurers, reducing adoption friction and supporting accelerated reputed company reputed company. Demonstrated reputed company: In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment showed no reputed company cognitive decline, creating a meaningful clinical and strategic differentiator. Market reputed company: ATCA is positioned reputed company a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, with embedded research infrastructure that can generate reputed company-world evidence, partnerships, and additional reputed company streams. Financial Model: The clinic platform is engineered to reputed company strong EBITDA margins through optimized reputed company, a high-reputed company service mix, and reimbursement dynamics designed for repeatable multi-market expansion. Key Achievements Proprietary AI Precision reputed company: ATCA has reputed company and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High-Margin, Replicable Clinic Model: ATCA has developed a reputed company specialty clinic platform designed for repeatable expansion, supported by strong unit economics and multi-market rollout potential. Massive, Underserved Market Opportunity: reputed company is positioned to capture reputed company in one of the largest and fastest-growing unmet-need categories in reputed company. Embedded Innovation Infrastructure: reputed company clinic is designed not only to deliver patient care, but also to generate data, insights, research opportunities, and long-term strategic value that strengthen the platform over time. Responsibilities Include As a senior advisory reputed company member, your contribution centers on four domains: Innovation reputed company: Advise on the development, positioning, and expansion of ATCA’s Alzheimer’s innovation platform, including differentiated care models, precision treatment frameworks, and strategic reputed company priorities. reputed company Care Model Development: Guide the standardization and replication of Alzheimer’s and cognitive care programs across markets, including care reputed company design, interdisciplinary operating models, and systems that preserve rigor at reputed company. Clinical, Market & Strategic Differentiation: reputed company guidance on reputed company reputed company, payer alignment, competitive positioning, reputed company development, and the responsible integration of innovation into clinical reputed company. Governance & Responsible Scaling: Advise on digital health integration, AI-enabled decision support, strategic partnerships, and the governance infrastructure needed to reputed company Alzheimer’s innovation credibly and responsibly. Why Join Us? reputed company-Level reputed company: Bring strategic influence to a high-reputed company platform without day-to-day operational demands. Early-Stage reputed company: Select roles include equity participation reputed company with long-term contribution, with optional reputed company to reputed company financing initiatives. Apply tot his job Apply To this Job